Comparative toxicokinetics of chlorinated and brominated haloacetates in F344 rats

Toxicology and Applied Pharmacology

Volumn 158, Issue 2, 1999, Pages 103-114

  Schultz, Irvin R ^a   Merdink, J L ^b   Gonzalez Leon, A ^b   Bull, Richard J ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

F344 rats; Haloacids; Metabolism

Indexed keywords

ACETIC ACID DERIVATIVE; DICHLOROACETIC ACID; TRICHLOROACETIC ACID;

ANIMAL EXPERIMENT; ARTICLE; DISINFECTION; KIDNEY CLEARANCE; MALE; METABOLIC RATE; NONHUMAN; RAT; URINARY EXCRETION; WATER TREATMENT;

ANIMALIA; RODENTIA;

EID: 0033566186     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8698     Document Type: Article

References (55)

1. Austin E. W., Bull R. J. The effect of pretreatment with dichloroacetate and trichloroacetate on the metabolism of bromodichloroacetate. J. Toxicol. Environ. Health. 52:1997;367-383.
2. Blakey G. E., Nestorov I. A., Arundel P. A., Aarons L. J., Rowland M. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat. J. Pharmacokinet. Biopharm. 25:1997;277-312.
3. Bowden D. J., Clegg S. L., Brimblecombe P. The Henry's law constants of the haloacetic acids. J. Atmos. Chem. 29:1998;85-107.
4. Bull R. J., Sanchez I. M., Nelson M. A., Larson J. L., Lansing A. L. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 63:1990;341-359.
5. Chen W. J., Weisel C. P. Halogenated DBP concentrations in a distribution system. J. AWWA. 90:1998;151-163.
6. Clewell R. J., Gentry P. R., Gearhart J. M., Allen B. C., Andersen M. E. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. Chemosphere. 31:1995;2561-2578.
7. Daniel F., DeAngelo A. B., Stauber J. A., Olson G. R., Page N. P. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 19:1992;159-168.
8. Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharmaceut. Res. 10:1993;1093-1095.
9. DeAngelo A. B., Daniel F. B., Stober J. A., Olson G. R. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16:1991;337-347.
10. DeAngelo A. B., Daniel F. B., Stober J. A., nad Olson G. R. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology. 114:1996;207-221.
11. Evans O. B. Dichloroacetate tissue concentrations and its relationship to hypolactatemia and pyruvate dehydrogenase activation. Biochem. Pharmacol. 31:1982;3124-3126.
12. Fisher J. W., Gargas M. L., Allen B. C., Andersen M. E. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol. Appl. Pharmacol. 109:1991;183-195.
13. Fox A. W., Sullivan B. W., Buffini J. D., Neichin M. L., Nicora R., Hoehler F. K., O'Rourke R., Stoltz R. R. Reduction of serum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships. J. Pharmacol. Exp. Ther. 279:1996;686-693.
14. Gibaldi M., Perrier D. Pharmacokinetics. 1982;Dekker, New York.
15. Giller S., Le Curieux F., Erb F., Marzin D. Comparative genotoxicity of halogenated acetic acids found in drinking water. Mutagenesis. 12:1997;321-328.
16. Glaser J. A., Foerst D. L., McKee G. D., Quave S. A., Budde W. L. Trace analyses for wastewaters. Environ. Sci. Technol. 15:1981;1426-1435.
17. Gonzalez-Leon A., Merdink J. L., Bull R. J., Schultz I. R. Inhibition of metabolism by chlorinated and brominated di-haloacetates and differential recovery in B6C3F1 mice and F344 rats. Toxicologist. 48:1999;206.
18. Gonzalez-Leon A., Schultz I. R., Bull R. J. Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prolonged administration in drinking water. Toxicol. Appl. Pharmacol. 146:1997;189-195.
19. Gray M. R., Tam Y. K. Pharmacokinetics of drugs that inactivate metabolic enzymes. J. Pharm. Sci. 80:1991;121-127.
20. Henderson G. N., Curry S. H., Derendorf H., Wright E. C., Stacpoole P. W. Pharmacokinetics of dichloroacetate in adult patients with lactic acidosis. J. Clin. Pharmacol. 37:1997;416-425.
21. Herren-Freund S. M., Pereira M. A., Koury M. D., Olson G. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 90:1987;183-189.
22. Hoke J. F., Ravis W. R. Evaluation of methods for estimating the rate constant of a 3-compartment absorption model when absorption and elimination rate constants are equal. J. Pharm. Sci. 81:1992;401-402.
23. Hunter E. S. 3rd, Rogers E. H., Schmid J. E., Richard A. Comparative effects of haloacetic acids in whole embryo culture. Teratology. 54:1996;57-64.
24. James M. O., Cornett R., Yan Z., Henderson G. N., Stacpoole P. W. Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats. Drug Metab. Dispos. 25:1997;1223-1227.
25. Janku I. Physiological modeling of renal clearance. Eur. J. Clin. Pharmacol. 44:1993;513-519.
26. Ketcha M. M., Stevens D. K., Warren D. A., Bishop C. T., Brashear W. T. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J. Anal. Toxicol. 20:1996;236-241.
27. Krasner S. W., McGuire M. J., Jacangelo J. G., Patania N. L., Reagen K. M., Aieta E. M. The occurrence of disinfection by-products in US drinking water. J. Am. Water Works Assoc. 81:1989;41-53.
28. Langguth P., Lee K. M., Spahn-Langguth H., Amidon G. L. Variable gastric emptying and discontinuities in drug absorption profiles: Dependence of rates and extent of cimetidine absorption on motility phase and pH. Biopharm. Drug Dispos. 15:1994;719-746.
29. Larson J. L., Bull R. J. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rat and mice. Toxicol. Appl. Pharmacol. 115:1992;268-277.
30. Lipscomb J. C., Mahle D. A., Brashear W. T., Brarton H. A. Dichloroacetic acid: Metabolism in cytosol. Drug Metab. Dispos. 23:1995;1203-1205.
31. Lilly P. D., Andersen M. E., Ross T. M., Pegram R. A. A physiologically based description of the oral uptake, tissue dosimetry and rates of metabolism of bromodichloromethane in the male rat. Toxicol. Appl. Pharmacol. 150:1998;205-217.
32. Lin E. L., Mattox J. K., Daniel F. B. Tissue distribution, excretion and urinary metabolites of dichloroacetic acid in the male fisher 344 rat. J. Toxicol. Environ. Health. 38:1993;19-32.
33. Linder R. E., Klinefelter G. R., Strader L. F., Suarez J. D., Dyer C. J. Acute spermatogenic effects of bromoacetic acids. Fundam. Appl. Toxicol. 22:1994;422-430.
34. Linder R. E., Klinefelter G. R., Strader L. F., Suarez J. D., Roberts N. L. Spermatotoxicity of dichloroacetic acid. Reprod. Toxicol. 11:1997;681-688.
35. Merdink J. L., Gonzalez-Leon A. G., Bull R. J., Schultz I. R. Dichloroacetic acid formation in B6C3F1 mice following administration of trichloroethylene or its metabolites. Toxicol. Sci. 45:1998;33-41.
36. Pereira M. A. Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam. Appl. Toxicol. 31:1996;192-199.
37. Pourmoghaddas H., Stevens A. A., Kinman R. N., Dressman R. C., Moore L. A., Ireland J. C. Effects of bromide ion on formation of HAAs during chlorination. J. Am. Water Works Assoc. 85:1993;82-87.
38. Reinoso R. F., Telfer B. A., Rowland M. Tissue water content in rats measured by desiccation. J. Pharmacol. Toxicol. Methods. 38:1997;87-92.
39. Richard A. M., Hunter S. E. Quantitative structure-activity relationships for the developmental toxicity of haloacetic acids in mammalian whole embryo culture. Teratology. 53:1996;352-360.
40. 2/UV disinfection byproducts in drinking water. Environ. Sci. Technol. 30:1996;3327-3334.
41. Rowland M., Tozer T. N. Clinical Pharmacokinetics: Concepts and Applications. 1989;Lea & Febbiger, Philadelphia.
42. Schultz I. R., Gonzalez-Leon A., Merdink J. L., Bull R. J. Comparative toxicokinetics and metabolism of halo-acetic acids in F344 rats. Toxicologist. 42:1998;212.
43. Shangraw R. E., Fisher D. M. Pharmacokinetics of dichloroacetate in patients undergoing liver transplantation. Anesthesiology. 84:1996;851-858.
44. Singer P. C. Formation and characterization of disinfection by-products. Craun G. F. Safety of Water Disinfection: Balancing Chemical and Microbial Tisks. 1993;201-219 International Life Sciences Institute, Washington.
45. Singer P. C., Chang S. D. Correlations between trihalomethanes and total organic halides formed during water treatment. J. Am. Water Works Assoc. 81:1989;61-65.
46. Stauber A. J., Bull R. J. Different modes of action of chlorinated and brominated haloacetates. Toxicologist. 15:1995;232.
47. Stenner R. D., Merdink J. L., Fisher J. W., Bull R. J. Physiologically based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. Risk Anal. 18:1998;261-269.
48. Stopher D., McClean S. An improved method for the determination of distribution coefficients. J. Pharm. Pharmacol. 42:1990;144.
49. Suttle A. B., Pollack G. M., Brouwer K. L. Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles. Pharm. Res. 9:1992;350-356.
50. Tong Z., Board P. G., Anders M. W. Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331:1998a;371-374.
51. Tong Z., Board P. G., Anders M. W. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem. Res. Toxicol. 11:1998b;1332-1338.
52. Toon S., Rowland M. Structure-pharmacokinetic relationships among the barbiturates in the rat. J. Pharm. Exp. Ther. 225:1983;752-763.
53. Walker D. K., Beaumont K. C., Stopher D. A., Smith D. A. Pharmacokinetics of a series of bis(methanesulphonamido-arylalkyl)amines in the beagle dog. Xenobiotica. 26:1996;1101-1111.
54. Williams D. T., Lebel G. L., Benoit F. M. Disinfection by-products in canadian drinking water. Chemosphere. 34:1997;299-316.
55. Xu G., Stevens D. K., Bull R. J. Metabolism of bromodichloroacetate in B6C3F1 mice. Drug. Metab. Dispos. 23:1995;1412-1416.